biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Sadly, I Think It's Checkmate

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 17, 2023 8:58pm

126 Views

Post# 35229580

RE:RE:Sadly, I Think It's Checkmate

Lind has a death grip, narmac. It's hard to believe that Rathjen could let things go this badly for so long without giving shareholders a chance to help fix it. We knew only in the end that Lind wasn't going to help. The problem, of course, is that Bioasis knew many months ago that Lind had that death grip on Bioasis.

I called the webinar a funeral and that I was appalled by reports that Rathjen was apparently a happy person in the webinar. She's touting herself as saving Bioasis.

In fact, she failed. She couldn't do the job and she didn't. But she gets the industry standard reward of Happy Ever After for her efforts.

jd

<< Previous

Bullboard Posts

Next >>

Abcourt Mines launches Flordin property drill campaign